Skip to content
Disclosery

Privium Fund Management B.V.

Follow

13F filer, CIK 1795097, AMSTERDAM, Netherlands

Privium Fund Management B.V. reported $543,130,707 across 57 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-03. Its ten largest share positions make up 68.19% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001754960-26-000150

Period
2025-12-31
Reported value
$543M
Holdings
57
Top 10 weight
68.19%
New
6
Sold out
8

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LMNDadded+103,259$7.35M
IRENadded+150,000$5.67M
VRDNnew+173,516$5.4M
BIIBadded+21,555$3.79M
ENGNnew+352,087$3.18M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SPOTreduced-27,000-$15.7M
TSLAreduced-15,500-$6.97M
AMZNreduced-28,000-$6.46M
ARWRreduced-75,747-$5.03M
MRKreduced-27,800-$2.93M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001754960-26-000150, largest first. % of portfolio is the value over $543,130,707, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TSLATESLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 216,000 shares; 2024Q4: 220,000 shares; 2025Q1: 220,000 shares; 2025Q2: 242,000 shares; 2025Q3: 244,000 shares; 2025Q4: 228,500 shares 228,500$103M18.92%-15,500Timeline
SHOPSHOPIFY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 415,000 shares; 2024Q4: 415,000 shares; 2025Q1: 415,000 shares; 2025Q2: 430,000 shares; 2025Q3: 415,000 shares; 2025Q4: 410,000 shares 410,000$66M12.15%-5,000Timeline
SPOTSPOTIFY TECHNOLOGY S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 149,000 shares; 2024Q4: 145,000 shares; 2025Q1: 145,000 shares; 2025Q2: 114,000 shares; 2025Q3: 95,000 shares; 2025Q4: 68,000 shares 68,000$39.5M7.27%-27,000Timeline
PLTRPALANTIR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 475,000 shares; 2024Q4: 370,000 shares; 2025Q1: 360,000 shares; 2025Q2: 350,000 shares; 2025Q3: 200,000 shares; 2025Q4: 200,000 shares 200,000$35.5M6.55%0Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 141,000 shares; 2024Q4: 141,000 shares; 2025Q1: 141,000 shares; 2025Q2: 149,000 shares; 2025Q3: 149,000 shares; 2025Q4: 121,000 shares 121,000$27.9M5.14%-28,000Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 333,356 shares; 2024Q4: 380,586 shares; 2025Q1: 629,214 shares; 2025Q2: 612,214 shares; 2025Q3: 473,951 shares; 2025Q4: 398,204 shares 398,204$26.4M4.87%-75,747Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 250,744 shares; 2024Q4: 266,794 shares; 2025Q1: 267,594 shares; 2025Q2: 267,594 shares; 2025Q3: 248,894 shares; 2025Q4: 240,824 shares 240,824$19.1M3.51%-8,070Timeline
COINCOINBASE GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 70,000 shares; 2025Q3: 79,000 shares; 2025Q4: 79,000 shares 79,000$17.9M3.29%0Timeline
LMNDLEMONADE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 145,000 shares; 2025Q4: 248,259 shares 248,259$17.7M3.25%+103,259Timeline
SESEA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 210,000 shares; 2024Q4: 210,000 shares; 2025Q1: 210,000 shares; 2025Q2: 210,000 shares; 2025Q3: 160,000 shares; 2025Q4: 138,000 shares 138,000$17.6M3.24%-22,000Timeline
NVDANVIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 73,000 shares; 2024Q4: 73,000 shares; 2025Q1: 73,000 shares; 2025Q2: 81,000 shares; 2025Q3: 81,000 shares; 2025Q4: 81,000 shares 81,000$15.1M2.78%0Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 20,500 shares; 2025Q3: 51,925 shares; 2025Q4: 73,480 shares 73,480$12.9M2.38%+21,555Timeline
AMDADVANCED MICRO DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares; 2025Q4: 60,000 shares 60,000$12.8M2.37%0Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,632,388 shares; 2024Q4: 4,985,633 shares; 2025Q1: 4,985,633 shares; 2025Q2: 4,997,562 shares; 2025Q3: 4,998,287 shares; 2025Q4: 5,357,762 shares 5,357,762$10.8M1.99%+359,475Timeline
IRENIREN LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,000 shares; 2025Q4: 280,000 shares 280,000$10.6M1.95%+150,000Timeline
ASTSAST SPACEMOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 821,267 shares; 2024Q4: 111,500 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 110,000 shares; 2025Q4: 145,000 shares 145,000$10.5M1.94%+35,000Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 80,232 shares; 2024Q4: 62,232 shares; 2025Q1: 52,732 shares; 2025Q2: 52,732 shares; 2025Q3: 52,732 shares; 2025Q4: 56,878 shares 56,878$10.4M1.91%+4,146Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 744,916 shares; 2024Q4: 742,162 shares; 2025Q1: 579,139 shares; 2025Q2: 447,486 shares; 2025Q3: 386,000 shares; 2025Q4: 416,270 shares 416,270$9.96M1.83%+30,270Timeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 325,709 shares; 2025Q1: 325,709 shares; 2025Q2: 344,472 shares; 2025Q3: 305,972 shares; 2025Q4: 305,972 shares 305,972$8.89M1.64%0Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 242,512 shares; 2024Q4: 258,380 shares; 2025Q1: 249,804 shares; 2025Q2: 253,304 shares; 2025Q3: 289,804 shares; 2025Q4: 357,502 shares 357,502$8.22M1.51%+67,698Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 173,516 shares 173,516$5.4M0.99%newTimeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 27,691 shares; 2025Q1: 107,622 shares; 2025Q2: 107,622 shares; 2025Q3: 196,622 shares; 2025Q4: 214,622 shares 214,622$5.03M0.93%+18,000Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,300 shares; 2025Q2: 8,300 shares; 2025Q3: 8,300 shares; 2025Q4: 9,355 shares 9,355$4.24M0.78%+1,055Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,111 shares; 2024Q4: 72,611 shares; 2025Q1: 41,093 shares; 2025Q2: 59,093 shares; 2025Q3: 64,393 shares; 2025Q4: 36,593 shares 36,593$3.85M0.71%-27,800Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 48,834 shares; 2024Q4: 88,000 shares; 2025Q1: 113,550 shares; 2025Q2: 135,550 shares; 2025Q3: 170,000 shares; 2025Q4: 193,010 shares 193,010$3.28M0.6%+23,010Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 352,087 shares 352,087$3.18M0.59%newTimeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,987 shares; 2025Q3: 19,000 shares; 2025Q4: 33,300 shares 33,300$3.17M0.58%+14,300Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,350 shares; 2024Q4: 9,250 shares; 2025Q1: 7,510 shares; 2025Q2: 9,320 shares; 2025Q3: 12,170 shares; 2025Q4: 12,170 shares 12,170$3M0.55%0Timeline
ABEVAMBEV SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 622,314 shares; 2024Q4: 652,357 shares; 2025Q1: 804,206 shares; 2025Q2: 795,786 shares; 2025Q3: 897,134 shares; 2025Q4: 1,063,174 shares 1,063,174$2.63M0.48%+166,040Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 215,624 shares; 2024Q4: 185,062 shares; 2025Q1: 132,189 shares; 2025Q2: 132,189 shares; 2025Q3: 132,189 shares; 2025Q4: 132,189 shares 132,189$2.33M0.43%0Timeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,347 shares; 2024Q4: 34,997 shares; 2025Q1: 60,097 shares; 2025Q2: 44,700 shares; 2025Q3: 40,000 shares; 2025Q4: 42,874 shares 42,874$2.25M0.41%+2,874Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 61,000 shares; 2025Q4: 71,500 shares 71,500$1.98M0.36%+10,500Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 138,115 shares; 2025Q1: 160,198 shares; 2025Q2: 178,356 shares; 2025Q3: 192,356 shares; 2025Q4: 192,550 shares 192,550$1.91M0.35%+194Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 55,000 shares 55,000$1.75M0.32%newTimeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 213,960 shares; 2024Q4: 225,078 shares; 2025Q1: 117,000 shares; 2025Q2: 163,000 shares; 2025Q3: 163,000 shares; 2025Q4: 200,000 shares 200,000$1.59M0.29%+37,000Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 98,500 shares; 2024Q4: 121,000 shares; 2025Q1: 131,000 shares; 2025Q2: 197,458 shares; 2025Q3: 197,458 shares; 2025Q4: 210,000 shares 210,000$1.57M0.29%+12,542Timeline
SLBSLB LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 19,697 shares; 2025Q4: 38,805 shares 38,805$1.49M0.27%+19,108Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,482 shares; 2024Q4: 82,476 shares; 2025Q1: 75,576 shares; 2025Q2: 103,433 shares; 2025Q3: 47,000 shares; 2025Q4: 49,594 shares 49,594$1.46M0.27%+2,594Timeline
HIMSHIMS & HERS HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,000 shares; 2025Q3: 40,000 shares; 2025Q4: 40,000 shares 40,000$1.3M0.24%0Timeline
RNACCARTESIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 172,500 shares 172,500$1.24M0.23%newTimeline
VZLAVIZSLA SILVER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 116,521 shares; 2024Q4: 116,521 shares; 2025Q1: 192,487 shares; 2025Q2: 250,790 shares; 2025Q3: 204,654 shares; 2025Q4: 204,654 shares 204,654$1.12M0.21%0Timeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,978 shares; 2024Q4: 21,978 shares; 2025Q1: 32,327 shares; 2025Q2: 37,029 shares; 2025Q3: 37,750 shares; 2025Q4: 37,750 shares 37,750$940K0.17%0Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 39,400 shares; 2025Q3: not reported; 2025Q4: 43,000 shares 43,000$925K0.17%newTimeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 120,000 shares; 2024Q4: 134,900 shares; 2025Q1: 134,900 shares; 2025Q2: 134,900 shares; 2025Q3: 134,900 shares; 2025Q4: 164,900 shares 164,900$907K0.17%+30,000Timeline
NOVNOV INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 37,925 shares; 2024Q4: 42,889 shares; 2025Q1: 49,745 shares; 2025Q2: 63,876 shares; 2025Q3: 63,876 shares; 2025Q4: 53,126 shares 53,126$830K0.15%-10,750Timeline
SASEABRIDGE GOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 32,087 shares; 2024Q4: 35,987 shares; 2025Q1: 44,074 shares; 2025Q2: 44,074 shares; 2025Q3: 48,474 shares; 2025Q4: 23,756 shares 23,756$703K0.13%-24,718Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 185,639 shares; 2024Q4: 231,674 shares; 2025Q1: 251,674 shares; 2025Q2: 294,142 shares; 2025Q3: 308,837 shares; 2025Q4: 326,245 shares 326,245$649K0.12%+17,408Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 294,800 shares; 2024Q4: 397,650 shares; 2025Q1: 432,760 shares; 2025Q2: 432,760 shares; 2025Q3: 432,760 shares; 2025Q4: 170,146 shares 170,146$597K0.11%-262,614Timeline
RIGTRANSOCEAN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 102,000 shares; 2025Q4: 139,604 shares 139,604$577K0.11%+37,604Timeline
SDSANDRIDGE ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,300 shares; 2024Q4: 23,300 shares; 2025Q1: 23,300 shares; 2025Q2: 37,022 shares; 2025Q3: 50,392 shares; 2025Q4: 38,792 shares 38,792$560K0.1%-11,600Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 21,645 shares; 2025Q2: 25,241 shares; 2025Q3: 45,000 shares; 2025Q4: 95,000 shares 95,000$373K0.07%+50,000Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,000 shares; 2024Q4: 87,000 shares; 2025Q1: 109,026 shares; 2025Q2: 111,090 shares; 2025Q3: 333,219 shares; 2025Q4: 369,100 shares 369,100$363K0.07%+35,881Timeline
VALVALARIS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,611 shares; 2024Q4: 14,182 shares; 2025Q1: 20,222 shares; 2025Q2: 13,803 shares; 2025Q3: 8,315 shares; 2025Q4: 6,315 shares 6,315$318K0.06%-2,000Timeline
NENOBLE CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,525 shares; 2024Q4: 10,525 shares; 2025Q1: 14,287 shares; 2025Q2: 14,287 shares; 2025Q3: 14,287 shares; 2025Q4: 10,849 shares 10,849$306K0.06%-3,438Timeline
URNMSPROTT FDS TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,856 shares; 2024Q4: 10,276 shares; 2025Q1: 12,114 shares; 2025Q2: 16,278 shares; 2025Q3: 11,448 shares; 2025Q4: 5,407 shares 5,407$297K0.05%-6,041Timeline
TDWTIDEWATER INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,350 shares; 2025Q3: 5,483 shares; 2025Q4: 5,483 shares 5,483$277K0.05%0Timeline
NOMDNOMAD FOODS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,199 shares 8,199$103K0.02%newTimeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ABVXABIVAX SA30,412$2.58Mshares
RNAMAVIDITY BIOSCIENCES INC53,000$2.31Mshares
ROIVROIVANT SCIENCES LTD126,923$1.92Mshares
ACADACADIA PHARMACEUTICALS INC70,400$1.5Mshares
ALXOALX ONCOLOGY HLDGS INC509,059$932Kshares
PAASPAN AMERN SILVER CORP18,531$718Kshares
RXRXRECURSION PHARMACEUTICALS IN119,000$581Kshares
SBSWSIBANYE STILLWATER LTD26,232$295Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001754960-26-000150 base2026-02-03acceptance time not in the bulk data set